Fig. 5From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancerCalibration plots of the NNMT-related nomogram to predict OS. (A-C) Calibration plots of the NNMT-related nomogram to predict OS at 1 year (a), 3 years (b), and 5 years (c) in GSE9891 dataset. d-f Calibration plots of the NNMT-related nomogram to predict OS at 1 year (d), 3 years (e), and 5 years (f) in TCGA datasetBack to article page